MM
Mark C. McKenna

Mark C. McKenna insider trades: Apogee Therapeutics (APGE) stock buys and sales

Apogee Therapeutics Last trade Dec 12, 2024 29 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
6
Open-market trades
since 2019
7
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mark reports to the SEC

and 1 more company

Open-market buys and sales

6 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 12, 2024APGE↑ Buy$991K
Mar 15, 2023RXDX↓ Sell$2.9M
Mar 3, 2023RXDX↓ Sell$1.4M
Feb 17, 2023RXDX↓ Sell$7.7M
Jan 17, 2023RXDX↓ Sell$3.0M
Aug 19, 2019BHC↓ Sell$235K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other APGE insiders

Open-market trades in the last 12 months

About Mark C. McKenna's insider trades

Mark C. McKenna is an insider at Apogee Therapeutics (APGE). Since Aug 19, 2019, Mark has reported 1 open-market purchase worth $991K and 5 sales worth $15.2M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings), option exercises (7 filings), shares withheld for taxes (4 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every APGE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.